Viewing Study NCT02230761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:35 PM
Ignite Modification Date: 2026-02-02 @ 6:19 PM
Study NCT ID: NCT02230761
Status: COMPLETED
Last Update Posted: 2016-02-08
First Post: 2014-08-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)
Sponsor: Topokine Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lower Eyelid Steatoblepharon (Excess Eyelid Fat) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None steatoblepharon View
None blepharoptosis View
None dermatochalasis View
None blepharoplasty View
None periorbital View
None orbital View
None eyelid View
None eyebags View
None eye bags View